Changes in stent platform, polymer, and drug components have led to improved outcomes.
New stent platforms may offer enhanced performance, safety, and efficacy characteristics.
Mark A. Turco, MD, FACC, an interventional cardiologist turned chief medical officer, offers a unique perspect...
An overview of the PARTNER trial and an update on the ongoing studies of transcatheter aortic valve replacemen...
The status of direct and indirect approaches to treating mitral regurgitation.
Cardiac Interventions Today interviews Carlos E. Ruiz, MD, PhD, who shares his expertise on the curre...

This Buyer's Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.
The charts include sizes, configurations, and unique characteristics of each product, listed alphabetically by manufacturer name. You will also find links to download printable PDFs of each chart. We hope that this guide will be a useful tool in your practice.
New device iterations and the latest trial data that could change your practice. more >
How drug-eluting platforms are being enhanced to improve patient outcomes. more >
Welcome to the Cardiac Interventions Today 2012 Buyer's Guide, our comprehensive guide to the devices used in coronary and cardiac interventions. more >
Welcome to Cardiac Interventions Today, a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007, with its launch issue focusing on the state of coronary drug-eluting stent use. Each edition will cover a variety of topics in a flexible format that includes articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's cardiology practices.